Tirbanibulin Compared to 5-Fluorouracil for Treatment of Actinic Keratosis
April 19th 2021Todd Schlesinger, MD, FAAD, outlines his research on newly FDA-approved topical tirbanibulin (Klisyri, Almirall) for treatment of actinic keratosis (AK), as well as compares it to another topical treatment for AK, 5-fluorouracil.